# Succinylated Gelatin

## Gelofusine 500mL 4%

| 藥物代碼 | IGEL |
| :--- | :--- |
| 適應症 | Primary vol replacement in hypovolaemia & shock due to acute blood or fluid loss, burns & sepsis; prophylaxis of hypotension during epidural or spinal anaesth; haemodilution & autologous transfusion; extracorporeal circulation \(haemodialysis, heart lung machine\). |
| 副作用 | As with all colloidal vol substitutes, allergic, \(anaphylactic or anaphylactoid\) reactions of varying severity can occur after infusion of Gelafundin/Gelofusine. |
| 禁忌 | Hypervolemia; hyperhydration; severe cardiac insufficiency; severe bleeding disorders; severe renal insufficiency. |
| 藥物保存方式 | N/A |
| 用法用量 | Compensation of minor losses of blood or plasma, pre- & intraoperative routine prophylaxis 500-1,000 mL infused over 1-3 hr. Major losses of blood or plasma Average dose is between 1,000 & 2,000 mL. Emergency situations or shock conditions Initially 500 mL administered by forced infusion over 5-10 mins. Thereafter, the infusion can be continued with doses corresponding to actual losses of blood or plasma. During extracorporal circulation Normally, between 500-1,000 mL. |
| 肝功能異常 | 無需調整劑量  Use with extreme caution |
| 腎功能異常 | 無需調整劑量 |
| 懷孕用藥危分級 | 尚未確立 |
| 孕期用藥建議 | N/A |
| 附帶說明 | N/A |
| 哺乳期用藥建議 | Unknown 尚未建立 |
| 附帶說明 | N/A |
| 注射劑給藥建議途徑 | IVD |
| 乾粉稀釋液 | N/A |
| 輸注點滴液 | N/A |
| IVP 用法建議 | N/A |
| IVD 用法建議 | 500~1000 mL 滴注超過 1-3 hs |
| 注意事項 | 此產品廠商未做相容性試驗，故不建議稀釋使用 |

